Go to Contents Go to Navigation

Pfizer vaccines for 218,000 people to arrive in S. Korea on Wednesday

All News 13:34 May 04, 2021

By Kim Han-joo

SEOUL, May 4 (Yonhap) -- Another batch of Pfizer Inc.'s COVID-19 vaccines for around 218,000 members of the general public aged 75 and over, and other virus-vulnerable groups will arrive in South Korea later this week, health authorities said Tuesday.

The products are part of a direct contract for 3.3 million people between the U.S. pharmaceutical firm and the Seoul government, the Korea Disease Control and Prevention Agency (KDCA) said.

So far, Pfizer vaccines, under the direct contract, for 1 million people have already been shipped in, with another shipment of the products for 875,000 people slated for later this month and 1.62 million people in June, it said.

People wait for COVID-19 vaccine shots at an injection center in central Seoul, in the file photo taken May 3, 2021. (Yonhap)

.

The first batch of Pfizer vaccines under the World Health Organization's global vaccine COVAX Facility project for around 50,000 front-line health care workers treating COVID-19 patients was distributed in late February.

Vaccines provided by Pfizer are given at state-run vaccination facilities, as the products require ultra-cold chain storage.

South Korea has secured enough COVID-19 vaccines to inoculate 99 million people under COVAX and separate contracts with five foreign drug firms, including Pfizer.

On Monday, the authorities said they will ramp up the vaccination campaign by importing more vaccines before June amid concerns over a tight supply, which caused the nationwide rollout to lag.

The KDCA said the country will receive 14.2 million doses of vaccines in May and June, enough to vaccinate up to 13 million people by end-June.

The country has inoculated some 3.46 million people since its vaccine rollout in late February. A total of 4.12 million doses of vaccines had been shipped in as of Monday.

khj@yna.co.kr
(END)

Keywords
HOME TOP
Send Feedback
How can we improve?
Thanks for your feedback!